These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22717365)

  • 21. [Effect of survivin shRNA on chemosensitivity of human ovarian cancer cell line OVCAR3 to paclitaxel].
    Yan XJ; Liang LZ; Zeng ZY; Shi Z; Fu LW
    Ai Zheng; 2006 Apr; 25(4):398-403. PubMed ID: 16613669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug.
    Zhao F; Yin H; Li J
    Biomaterials; 2014 Jan; 35(3):1050-62. PubMed ID: 24189097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Co-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancer.
    Yin T; Wang L; Yin L; Zhou J; Huo M
    Biomaterials; 2015 Aug; 61():10-25. PubMed ID: 25996409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.
    Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y
    Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression.
    Jang YL; Yun UJ; Lee MS; Kim MG; Son S; Lee K; Chae SY; Lim DW; Kim HT; Kim SH; Jeong JH
    Int J Pharm; 2012 Sep; 434(1-2):488-93. PubMed ID: 22613208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes.
    Yu B; Tang C; Yin C
    Biomaterials; 2014 Aug; 35(24):6369-78. PubMed ID: 24818887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(β-amino esters).
    Yin Q; Shen J; Chen L; Zhang Z; Gu W; Li Y
    Biomaterials; 2012 Sep; 33(27):6495-506. PubMed ID: 22704597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro &in vivo targeting behaviors of biotinylated Pluronic F127/poly(lactic acid) nanoparticles through biotin-avidin interaction.
    Xiong XY; Guo L; Gong YC; Li ZL; Li YP; Liu ZY; Zhou M
    Eur J Pharm Sci; 2012 Aug; 46(5):537-44. PubMed ID: 22538053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. iRGD conjugated TPGS mediates codelivery of paclitaxel and survivin shRNA for the reversal of lung cancer resistance.
    Shen J; Meng Q; Sui H; Yin Q; Zhang Z; Yu H; Li Y
    Mol Pharm; 2014 Aug; 11(8):2579-91. PubMed ID: 24236909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paclitaxel-induced apoptosis is blocked by camptothecin in human breast and pancreatic cancer cells.
    Jeansonne DP; Koh GY; Zhang F; Kirk-Ballard H; Wolff L; Liu D; Eilertsen K; Liu Z
    Oncol Rep; 2011 May; 25(5):1473-80. PubMed ID: 21331447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-Delivery of Curcumin and Paclitaxel by "Core-Shell" Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer.
    Zhao MD; Li JQ; Chen FY; Dong W; Wen LJ; Fei WD; Zhang X; Yang PL; Zhang XM; Zheng CH
    Int J Nanomedicine; 2019; 14():9453-9467. PubMed ID: 31819443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
    Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
    J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
    Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
    Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
    Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
    Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implication of the Akt2/survivin pathway as a critical target in paclitaxel treatment in human ovarian cancer cells.
    Weng D; Song X; Xing H; Ma X; Xia X; Weng Y; Zhou J; Xu G; Meng L; Zhu T; Wang S; Ma D
    Cancer Lett; 2009 Jan; 273(2):257-65. PubMed ID: 18842333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy.
    Han L; Tang C; Yin C
    Biomaterials; 2014 May; 35(15):4589-600. PubMed ID: 24613049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
    Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
    Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effects of Akt1 shRNA and paclitaxel-incorporated conjugated linoleic acid-coupled poloxamer thermosensitive hydrogel on breast cancer.
    Guo DD; Hong SH; Jiang HL; Kim JH; Minai-Tehrani A; Kim JE; Shin JY; Jiang T; Kim YK; Choi YJ; Cho CS; Cho MH
    Biomaterials; 2012 Mar; 33(7):2272-81. PubMed ID: 22177840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
    Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
    Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.